Free shipping on all orders over $ 500

Zardaverine

Cat. No. M27648

All AbMole products are for research use only, cannot be used for human consumption.

Zardaverine Structure

Price and Availability

For this product's availability, delivery time and price, please email inquiry@abmole.com directly or click the "Inquiry Now" button below.


Quality Control & Documentation
Biological Activity

Zardaverine is an orally active and selective PDE3/4 inhibitor (IC50)=0.58 uM/0.17 uM) with potent bronchodilator activity. Zardaverine also selectively inhibits the proliferation of HCC cells and induces apoptosis and cycle arrest (G0/G1 phase). Zardaverine has good antitumor potential and is effective in both bronchial relaxation and reduction of inflammation in asthma.

Chemical Information
Molecular Weight 268.22
Formula C12H10F2N2O3
CAS Number 101975-10-4
Form Solid
Solubility (25°C) DMSO 25 mg/mL (ultrasonic)
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Liping Sun, et al. PLoS One. Phosphodiesterase 3/4 inhibitor zardaverine exhibits potent and selective antitumor activity against hepatocellular carcinoma both in vitro and in vivo independently of phosphodiesterase inhibition

[2] R T Schermuly, et al. Eur Respir J. Zardaverine and aerosolised iloprost in a model of acute respiratory failure

[3] C Schudt, et al. Agents Actions Suppl. Zardaverine: a cyclic AMP specific PDE III/IV inhibitor

[4] C Schudt, et al. Biochem Pharmacol. Zardaverine as a selective inhibitor of phosphodiesterase isozymes

Related PDE Products
GSK256066

GSK256066 is a selective phosphodiesterase 4 (PDE4)inhibitor with an IC50 of 3.2 pM. *The compound is unstable in solutions, freshly prepared is recommended

BAY-60-7550

BAY-60-7550 is a potent PDE2 inhibitor with IC50 values of 2.0 nM (bovine) and 4.7 nM (human).

Roflumilast

Roflumilast (APTA-2217; BYK 20869; B9302-107) is a novel and selective, long-acting inhibitor of phosphodiesterase 4 (PDE-4).

Piclamilast

Piclamilast (RP 73401) is a potent and selective inhibitor of phosphodiesterase (PDE) 4.

Apremilast

Apremilast is a novel, orally available small molecule inhibitor of PDE4 with IC50 of 74 nM. Apremilast inhibits TNF-α release by lipopolysaccharide (LPS) with an IC50 of 104 nM.

  Catalog
Abmole Inhibitor Catalog




Keywords: Zardaverine supplier, PDE, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.